Voices from the Field
World Cancer Day: Next Generation Sequencing at the Forefront of Precision MedicineFebruary 4th 2023
Next generation sequencing is at the forefront of where technology and oncology intersect to help optimize patient outcomes and expand the overall field of cancer care.
Cervical Cancer Awareness Month: Dramatic Increase in Cervical Cancer Research Is Driving Treatment ProgressJanuary 16th 2023
For cervical cancer awareness month, Lauren Bollinger, MD, discusses how the increase in research in the field of cervical cancer is driving the progress of treatment.
Gender-Specific AI Model Advances Understanding of Glioblastoma Progression and Treatment ResponseSeptember 21st 2022
Distinguishing on current imaging between disease progression and pseudo progression in patients with glioblastoma is one of the most difficult clinical problems, according to Manmeet Ahluwalia, MD and Pallavi Tiwari, PhD.
No-Shave November: The Benefits of the Transperineal Versus Transrectal Approach to Prostate Cancer BiopsyNovember 16th 2021
Matthew J. Allaway, DO, discusses the need for a safe, precise and efficient option for performing prostate cancer biopsies via the transperineal approach and the limitations with the current standard of care, which is the transrectal approach, during No-Shave November awareness month.
PR-Driven Approaches to Treating Granulosa Cell TumorsOctober 16th 2021
Even though most early stage adult patients with granulosa cell tumors experience an excellent outcome, up to 33% of patients will eventually develop a tumor relapse. Recurrence may be detected many years after the initial treatment, thus prolonged surveillance is necessary.
MRI-Guided Radiation Therapy: A Novel Treatment for Pancreatic CancerSeptember 16th 2021
Complete surgical removal of a pancreatic tumor is not possible for most patients. Chemotherapy and radiation therapy are typically recommended to slow tumor growth, but ultimately are not expected to be curative, writes Michael Chuong, MD.
Risk Information Can Influence Clinical Decision-Making in MelanomaJuly 27th 2021
Cutaneous melanoma is disproportionately lethal among skin cancers, and as incidence rates of cutaneous melanoma continue to rise in the United States, so does the importance of managing melanoma cases in alignment with personalized prognoses.
For Patients with HIV and Cancer, a Multidisciplinary Treatment Approach is CriticalJuly 15th 2021
For people living with the one-two punch of both HIV and cancer, coordinated care by a multidisciplinary team that can bring extra resources to bear during treatment offers the best chance of a successful outcome.
Further Research Needed to Support Use of Checkpoint Inhibitors in Locally Advanced HNSCCMay 6th 2021
Avelumab was explored in a clinical trial for the treatment of locally advanced head and neck squamous cell carcinoma, but more research is needed to position the agent and other checkpoint inhibitors in the treatment landscape, experts say.